{"nct_id":"NCT06435429","title":"A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-08-13","start_date_type":"ACTUAL","primary_completion_date":"2028-09-26","primary_completion_date_type":"ESTIMATED","completion_date":"2031-11-26","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JAZZ"]}